Hologic Upgrades Aptima SARS-Cov-2 Assay Authorization To Full FDA Approval
Molecular Diagnostic Assay Secures FDA 510(k) Clearance
Hologic attains full US Food and Drug Administration 510(k) clearance for its Aptima SARS-CoV-2 assay, which reached market under an Emergency Use Authorization (EUA). Overall, Hologic’s “best-performing” molecular diagnostic business continues to grow despite the decline in revenue for COVID-19 assays and related items.
